A systematic review and meta-analysis of e-cigarette use among cancer survivors

A partir d'une revue systématique de la littérature publiée jusqu'en juin 2022 (23 articles), cette méta-analyse examine l'utilisation de la cigarette électronique chez les patients ayant survécu à un cancer et identifie les facteurs associés à cette utilisation

Résumé en anglais

Purpose: We conducted a systematic review and meta-analysis to determine the use of e-cigarettes among cancer survivors, factors associated with their use, and prevalence of e-cigarette use as a quit attempt.

Methods: We searched five electronic databases until June 2022. Two authors independently selected studies, appraised their quality, and collected data.

Results: Twenty-three publications from eight data sources (national surveys) met our eligibility criteria. The pooled rate of lifetime e-cigarette use among cancer survivors was 15% (95% CI 6–27%); current use was 3% (95% CI 0–8%). Among survivors who currently used traditional cigarettes, 63% (95% CI 57–69%) also used e-cigarettes. The reported rates of weighted lifetime e-cigarette use differed between age groups (18–44 years, up to 46.7%; 45–64, up to 27.2%; ≥65, up to 24.8%). Nine publications reported factors associated with lifetime e-cigarette use (i.e., active use of traditional cigarettes; heavy drinking; poor mental health; younger age; being male, non-Hispanic White, or single; having less than high school education or income ≤$25,000 USD; and living in the South regions of the US or urban areas). E-cigarettes were used as a quit resource by 75% of survivors reporting dual use of electronic and traditional cigarettes (95% CI 63%, 85%).

Conclusion: More than two-thirds of survivors currently using traditional cigarettes also use e-cigarettes. Higher use rates of e-cigarettes were reported among young cancer survivors compared to older survivors. Future studies are needed to assess the impact of e-cigarettes on long-term health and improve screening of smoking behaviors.

Implications for Cancer Survivors: Our study provides an overview of the prevalence of e-cigarette use and sociodemographic risk factors associated with e-cigarette use among cancer survivors. The findings can assist providers in supporting attempts to quit among cancer survivors.